W 670 (Lansoprazole delayed-release 30 mg)
Pill imprint W 670 has been identified as Lansoprazole delayed-release 30 mg.
Lansoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; helicobacter pylori infection; gastritis/duodenitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- W 670
- Strength:
- 30 mg
- Color:
- Pink / Black
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Wockhardt Limited
- National Drug Code (NDC):
- 64679-0670
- Inactive Ingredients:
- D&C Red No. 33
FD&C Blue No. 1
ferrosoferric oxide
gelatin
hypromelloses
magnesium carbonate
methacrylic acid - methyl methacrylate copolymer (1:1)
polyethylene glycol 6000
polysorbate 80
potassium hydroxide
propylene glycol
shellac
silicon dioxide
corn starch
sucrose
magnesium silicate
titanium dioxide
More about lansoprazole
Consumer resources
- Lansoprazole
- Lansoprazole delayed-release capsules
- Lansoprazole orally disintegrating tablets
- Lansoprazole powder packet
- Lansoprazole (Advanced Reading)
- Other brands: Prevacid, Prevacid SoluTab, Prevacid OTC, Prevacid IV
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
